Advancing Medical Breakthroughs with Nanotechnology Solutions

POP Biotechnologies develops platform technologies addressing critical needs in oncology and infectious disease.

Our Expertise

The Power of PoP

POP BIO uses two patented porphyrin-phospholipid (PoP) liposome technologies to create nanomedicines to address needs in immuno-oncology and infectious disease.

Accelerated Vaccine Development

The Spontaneous Nanoliposome Antigen Particleization (POP BIO SNAP) platform enables the rapid development of highly immunogenic vaccines

Targeted Chemotherapy

Chemophototherapy (CPT) using PoP liposomes to deliver targeted concentrations of chemotherapy drugs to tumors expose to specific laser light.

Discover Our Exciting Clinical Developments

Stay updated with our latest projects and collaborations in the field of biotechnology.

We are Actively Expanding Our Strong IP Protection

Exclusive license from SUNY for entire POP BIO SNAP and related patent portfolio

Formulations for MHC-I Restricted Epitope Immunization

Priority 1/2021

Particle based formulations of SAR-CoV-2 receptor binding domain

Priority 9/2020

Continuation In Part of above with examples in RSV, Influenza, and Lyme antigens

Priority 8/2019

Serum-stable Compositions and Methods for Light Triggered Release of Materials

Priority 9/2015
Canada 2981318
U.S.A. 15563703
European Union
Designated:
Belgium, France, Germany, United Kingdom,Italy, Ireland, Netherlands, Spain, Sweden, Switzerland EP3277264

Nanostructures comprising cobalt porphyrin-phospholipid conjugates and polyhistidine-tags

Priority 4/2015
Australia AU2016248454
Canada CA2981359
European Union
Belgium 167809961
United Kingdom EP16780996
Ireland 3283056
Netherlands EP3283056
Spain ES2865392
Sweden EP16780996.1
Switzerland 16780996

Compositions and Method for Light Triggered Release of Materials from Nanovesicles

Priority 12/2012
European Union
Belgium 2934303
Spain ES2764090
Switzerland 2934303
United Kingdom EP2934303
Italy 2934303
Netherlands EP2934303
Sweden EP2934303
France EP2934303
Hungary E13865112
Ireland 2934303